Assyro AI

FDA Orange Book · active-ingredient family

Flortaucipir f-18

Flortaucipir f-18 is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:TAUVID · NDA 212123

1

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
TAUVIDRLD×4AVID RADIOPHARMS INCNDA 212123May 28, 2020

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8932557May 26, 2032in 6 yr
Substance

Flortaucipir f-18 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.